In last trading session, PDS Biotechnology Corporation (NASDAQ:PDSB) saw 0.42 million shares changing hands with its beta currently measuring 1.87. Company’s recent per share price level of $3.82 trading at $0.09 or 2.41% at ring of the bell on the day assigns it a market valuation of $140.12M. That closing price of PDSB’s stock is at a discount of -168.85% from its 52-week high price of $10.27 and is indicating a premium of 32.2% from its 52-week low price of $2.59. Taking a look at company’s average trading volume volume of 897.86K if we extend that period to 3-months.

PDS Biotechnology Corporation (NASDAQ:PDSB) trade information

Upright in the green during last session for gaining 2.41%, in the last five days PDSB remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $3.82 price level, adding 3.54% to its value on the day. PDS Biotechnology Corporation’s shares saw a change of -23.14% in year-to-date performance and have moved 16.82% in past 5-day. PDS Biotechnology Corporation (NASDAQ:PDSB) showed a performance of 16.11% in past 30-days.

PDS Biotechnology Corporation (PDSB) estimates and forecasts

Statistics highlight that PDS Biotechnology Corporation is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -8.61% of value to its shares in past 6 months, showing an annual growth rate of -11.51% while that of industry is 12.80. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 42.97% during past 5 years.

PDSB Dividends

PDS Biotechnology Corporation is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.